Global BCG Vaccine Market, By Drug Type (Immune BCG, Therapy BCG), By Usage (Tuberculosis, Bladder Cancer), By End User (Pediatrics, Adults), and opportunities and forecast 2020-2027
BCG Vaccine Market Overview
Bacillus Calmette–Guerin (BCG) vaccine is usually given to newborn babies. Vaccination can be done from 6 months old to five years of age. According to World Health Organization, the annual risk of TB infection in children in high-burden countries is estimated to be 0.5-2%. Hence, BCG vaccines played an important role to protect newborns from tuberculosis and other similar diseases. This crucial factor is highly contributed to the growth of the global BCG vaccines market in the last few years.
Furthermore, increasing advancements in the vaccination camps. Also, solid campaigns in online and offline mode providing information to common people about proper vaccination in the current time. This important factor is expected to fuel the growth of the market. Also, the growing incidence of tuberculosis across the world and the rise in research activities for the development of the BCG vaccine are enhancing the market growth.
On the other hand, side effects and a global shortage of BCG vaccines may hamper the growth of the market. Besides, favorable government initiatives and a good focus on the vaccination programs globally are expected to open new opportunities for leading vendors of BCG vaccines in the forthcoming years.
BCG Vaccine Market Segment Overview
The immune BCG segment holds the highest share in the market. This is on account of the major role of BCG in effectively helping TB prevention and as of now, there is no substitute vaccine for immune BCG. In addition, several new vendors are focusing on developing new vaccinations for bladder cancer is anticipated to boost the market growth in the coming years.
BCG Vaccine Market Regional Overview
The market of the Asia Pacific is expected to grow at the fastest rate over the forecasted period. This is due to the high demand for BCG vaccines for the prevention of tuberculosis in the region. For instance, The Government of India has announced its plan to eliminate TB by 2025 during the Union Budget 2017–2018. Additionally, the market in Latin America and the Middle East, and Africa is expected to show noteworthy growth due to increasing awareness about the BCG vaccines.
BCG Vaccine Market Competitor overview
· In April 2020, the Serum Institute of India launched human trials to test the new BCG vaccine that can boost immunity in the fight against Covid-19.
BCG Vaccine Market, Key Players
· Intervax Ltd · Greensignal Bio Pharma Limited · AJ Vaccines · China National Pharmaceutical Group Corporation · Japan BCG Laboratory · Greensignal Bio Pharma Limited · Serum Institute of India Pvt. Ltd. · Merck & Company Inc · Sanofi S.A. · Statens Serum Institute · Gsbpl C · Shanghai Institute of Biological Products · Japan BCG Laboratory
BCG Vaccine Market Segmentation
BCG Vaccine Market, By Drug Type
· Immune BCG · Therapy BCG
BCG Vaccine Market, By Usage
· Tuberculosis · Bladder Cancer
BCG Vaccine Market, By End User
· Pediatrics · Adults
BCG Vaccine market, By Region
North America
US
Canada
Europe
UK
Germany
France
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
South Korea
Rest of Asia-Pacific
South America
Brazil
Argentina
Rest of South America
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
4. Key Insights
4.1. Key Emerging Trends – For Major Countries
4.2. Latest Technological Advancement
4.3. Regulatory Landscape
4.4. Industry SWOT Analysis
4.5. Porters Five Forces Analysis
5. Global BCG Vaccine Market Analysis (USD Billion), Insights and Forecast, 2020-2027
5.1. Key Findings / Summary
5.2. Market Analysis, Insights and Forecast – By Drug Type
5.2.1. Immune BCG
5.2.2. Therapy BCG
5.3. Market Analysis, Insights and Forecast – By Usage
5.3.1. Tuberculosis
5.3.2. Bladder Cancer
5.4. Market Analysis, Insights and Forecast – By End User
5.4.1. Pediatrics
5.4.2. Adults
5.5. Market Analysis, Insights and Forecast – By Region
5.5.1. North America
5.5.2. Latin America
5.5.3. Europe
5.5.4. Asia Pacific
5.5.5. Middle East and Africa
6. North America BCG Vaccine Market Analysis (USD Billion), Insights and Forecast, 2020-2027
6.1. Key Findings / Summary
6.2. Market Analysis, Insights and Forecast – By Drug Type
6.2.1. Immune BCG
6.2.2. Therapy BCG
6.3. Market Analysis, Insights and Forecast – By Usage
6.3.1. Tuberculosis
6.3.2. Bladder Cancer
6.4. Market Analysis, Insights and Forecast – By End User
6.4.1. Pediatrics
6.4.2. Adults
6.5. Market Analysis, Insights and Forecast – By Country
6.5.1. U.S.
6.5.2. Canada
7. Latin America BCG Vaccine Market Analysis (USD Billion), Insights and Forecast, 2020-2027
7.1. Key Findings / Summary
7.2. Market Analysis, Insights and Forecast – By Drug Type
7.2.1. Immune BCG
7.2.2. Therapy BCG
7.3. Market Analysis, Insights and Forecast – By Usage
7.3.1. Tuberculosis
7.3.2. Bladder Cancer
7.4. Market Analysis, Insights and Forecast – By End User
7.4.1. Pediatrics
7.4.2. Adults
7.5. Insights and Forecast – By Country
7.5.1. Brazil
7.5.2. Mexico
7.5.3. Rest of Latin America
8. Europe BCG Vaccine Market Analysis (USD Billion), Insights and Forecast, 2020-2027
8.1. Key Findings / Summary
8.2. Market Analysis, Insights and Forecast – By Drug Type
8.2.1. Immune BCG
8.2.2. Therapy BCG
8.3. Market Analysis, Insights and Forecast – By Usage
8.3.1. Tuberculosis
8.3.2. Bladder Cancer
8.4. Market Analysis, Insights and Forecast – By End User
8.4.1. Pediatrics
8.4.2. Adults
8.5. Market Analysis, Insights and Forecast – By Country
8.5.1. UK
8.5.2. Germany
8.5.3. France
8.5.4. Italy
8.5.5. Spain
8.5.6. Russia
8.5.7. Rest of Europe
9. Asia Pacific BCG Vaccine Market Analysis (USD Billion), Insights and Forecast, 2020-2027
9.1. Key Findings / Summary
9.2. Market Analysis, Insights and Forecast – By Drug Type
9.2.1. Immune BCG
9.2.2. Therapy BCG
9.3. Market Analysis, Insights and Forecast – By Usage
9.3.1. Tuberculosis
9.3.2. Bladder Cancer
9.4. Market Analysis, Insights and Forecast – By End User
9.4.1. Pediatrics
9.4.2. Adults
9.5. Market Analysis, Insights and Forecast – By Country
9.5.1. China
9.5.2. India
9.5.3. Japan
9.5.4. Australia
9.5.5. South East Asia
9.5.6. Rest of Asia Pacific
10. Middle East & Africa BCG Vaccine Market Analysis (USD Billion), Insights and Forecast, 2020-2027
10.1. Key Findings / Summary
10.2. Market Analysis, Insights and Forecast – By Drug Type
10.2.1. Immune BCG
10.2.2. Therapy BCG
10.3. Market Analysis, Insights and Forecast – By Usage
10.3.1. Tuberculosis
10.3.2. Bladder Cancer
10.4. Market Analysis, Insights and Forecast – By End User
10.4.1. Pediatrics
10.4.2. Adults
10.5. Market Analysis, Insights and Forecast – By Country
10.5.1. GCC
10.5.2. South Africa
10.5.3. Rest of Middle East & Africa
11. Competitive Analysis
11.1. Company Market Share Analysis, 2018
11.2. Key Industry Developments
11.3. Company Profile
11.4. Intervax Ltd
11.4.1. Business Overview
11.4.2. Segment 1 & Service Offering
11.4.3. Overall Revenue
11.4.4. Geographic Presence
11.4.5. Recent Development
*Similar details will be provided for the following companies
11.5. Greensignal Bio Pharma Limited
11.6. AJ Vaccines
11.7. China National Pharmaceutical Group Corporation
11.8. Japan BCG Laboratory
11.9. Greensignal Bio Pharma Limited
11.10. Serum Institute of India Pvt. Ltd.
11.11. Merck & Company Inc
11.12. Sanofi S.A.
11.13. Statens Serum Institute
11.14. Gsbpl C
11.15. Shanghai Institute of Biological Products
List of Figures
Figure 1: Global BCG Vaccine Market Revenue Breakdown (USD Billion, %) by Region, 2019 & 2027
Figure 2: Global BCG Vaccine Market Value Share (%), By Segment 1, 2019 & 2027
Figure 3: Global BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 4: Global BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 5: Global BCG Vaccine Market Value Share (%), By Segment 2, 2019 & 2027
Figure 6: Global BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 7: Global BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 8: Global BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 9: Global BCG Vaccine Market Forecast (USD Billion), by Others, 2016-2027
Figure 10: Global BCG Vaccine Market Value Share (%), By Segment 3, 2019 & 2027
Figure 11: Global BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 12: Global BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 13: Global BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 14: Global BCG Vaccine Market Forecast (USD Billion), by Others, 2016-2027
Figure 15: Global BCG Vaccine Market Value (USD Billion), by Region, 2019 & 2027
Figure 16: North America BCG Vaccine Market Value Share (%), By Segment 1, 2019 & 2027
Figure 17: North America BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 18: North America BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 19: North America BCG Vaccine Market Value Share (%), By Segment 2, 2019 & 2027
Figure 20: North America BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 21: North America BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 22: North America BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 23: North America BCG Vaccine Market Forecast (USD Billion), by Others, 2016-2027
Figure 24: North America BCG Vaccine Market Value Share (%), By Segment 3, 2019 & 2027
Figure 25: North America BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 26: North America BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 27: North America BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 28: North America BCG Vaccine Market Forecast (USD Billion), by Others, 2016-2027
Figure 29: North America BCG Vaccine Market Forecast (USD Billion), by U.S., 2016-2027
Figure 30: North America BCG Vaccine Market Forecast (USD Billion), by Canada, 2016-2027
Figure 31: Latin America BCG Vaccine Market Value Share (%), By Segment 1, 2019 & 2027
Figure 32: Latin America BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 33: Latin America BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 34: Latin America BCG Vaccine Market Value Share (%), By Segment 2, 2019 & 2027
Figure 35: Latin America BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 36: Latin America BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 37: Latin America BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 38: Latin America BCG Vaccine Market Forecast (USD Billion), by Others, 2016-2027
Figure 39: Latin America BCG Vaccine Market Value Share (%), By Segment 3, 2019 & 2027
Figure 40: Latin America BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 41: Latin America BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 42: Latin America BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 43: Latin America BCG Vaccine Market Forecast (USD Billion), by Others, 2016-2027
Figure 44: Latin America BCG Vaccine Market Forecast (USD Billion), by Brazil, 2016-2027
Figure 45: Latin America BCG Vaccine Market Forecast (USD Billion), by Mexico, 2016-2027
Figure 46: Latin America BCG Vaccine Market Forecast (USD Billion), by Rest of Latin America, 2016-2027
Figure 47: Europe BCG Vaccine Market Value Share (%), By Segment 1, 2019 & 2027
Figure 48: Europe BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 49: Europe BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 50: Europe BCG Vaccine Market Value Share (%), By Segment 2, 2019 & 2027
Figure 51: Europe BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 52: Europe BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 53: Europe BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 54: Europe BCG Vaccine Market Forecast (USD Billion), by Others, 2016-2027
Figure 55: Europe BCG Vaccine Market Value Share (%), By Segment 3, 2019 & 2027
Figure 56: Europe BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 57: Europe BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 58: Europe BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 59: Europe BCG Vaccine Market Forecast (USD Billion), by Others, 2016-2027
Figure 60: Europe BCG Vaccine Market Forecast (USD Billion), by U.K., 2016-2027
Figure 61: Europe BCG Vaccine Market Forecast (USD Billion), by Germany, 2016-2027
Figure 62: Europe BCG Vaccine Market Forecast (USD Billion), by France, 2016-2027
Figure 63: Europe BCG Vaccine Market Forecast (USD Billion), by Italy, 2016-2027
Figure 64: Europe BCG Vaccine Market Forecast (USD Billion), by Spain, 2016-2027
Figure 65: Europe BCG Vaccine Market Forecast (USD Billion), by Russia, 2016-2027
Figure 66: Europe BCG Vaccine Market Forecast (USD Billion), by Rest of Europe, 2016-2027
Figure 67: Asia Pacific BCG Vaccine Market Value Share (%), By Segment 1, 2019 & 2027
Figure 68: Asia Pacific BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 69: Asia Pacific BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 70: Asia Pacific BCG Vaccine Market Value Share (%), By Segment 2, 2019 & 2027
Figure 71: Asia Pacific BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 72: Asia Pacific BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 73: Asia Pacific BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 74: Asia Pacific BCG Vaccine Market Forecast (USD Billion), by Others, 2016-2027
Figure 75: Asia Pacific BCG Vaccine Market Value Share (%), By Segment 3, 2019 & 2027
Figure 76: Asia Pacific BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 77: Asia Pacific BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 78: Asia Pacific BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 79: Asia Pacific BCG Vaccine Market Forecast (USD Billion), by Others, 2016-2027
Figure 80: Asia Pacific BCG Vaccine Market Forecast (USD Billion), by China, 2016-2027
Figure 81: Asia Pacific BCG Vaccine Market Forecast (USD Billion), by India, 2016-2027
Figure 82: Asia Pacific BCG Vaccine Market Forecast (USD Billion), by Japan, 2016-2027
Figure 83: Asia Pacific BCG Vaccine Market Forecast (USD Billion), by Australia, 2016-2027
Figure 84: Asia Pacific BCG Vaccine Market Forecast (USD Billion), by Southeast Asia, 2016-2027
Figure 85: Asia Pacific BCG Vaccine Market Forecast (USD Billion), by Rest of Asia Pacific, 2016-2027
Figure 86: Middle East & Africa BCG Vaccine Market Value Share (%), By Segment 1, 2019 & 2027
Figure 87: Middle East & Africa BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 88: Middle East & Africa BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 89: Middle East & Africa BCG Vaccine Market Value Share (%), By Segment 2, 2019 & 2027
Figure 90: Middle East & Africa BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 91: Middle East & Africa BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 92: Middle East & Africa BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 93: Middle East & Africa BCG Vaccine Market Forecast (USD Billion), by Others, 2016-2027
Figure 94: Middle East & Africa BCG Vaccine Market Value Share (%), By Segment 3, 2019 & 2027
Figure 95: Middle East & Africa BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 96: Middle East & Africa BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 97: Middle East & Africa BCG Vaccine Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 98: Middle East & Africa BCG Vaccine Market Forecast (USD Billion), by Others, 2016-2027
Figure 99: Middle East & Africa BCG Vaccine Market Forecast (USD Billion), by GCC, 2016-2027
Figure 100: Middle East & Africa BCG Vaccine Market Forecast (USD Billion), by South Africa, 2016-2027
Figure 101: Middle East & Africa BCG Vaccine Market Forecast (USD Billion), by Rest of Middle East & Africa, 2016-2027
List of Tables
Table 1: Global BCG Vaccine Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 2: Global BCG Vaccine Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 3: Global BCG Vaccine Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 4: Global BCG Vaccine Market Revenue (USD Billion) Forecast, by Region, 2016-2027
Table 5: North America BCG Vaccine Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 6: North America BCG Vaccine Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 7: North America BCG Vaccine Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 8: North America BCG Vaccine Market Revenue (USD Billion) Forecast, by Country, 2016-2027
Table 9: Europe BCG Vaccine Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 10: Europe BCG Vaccine Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 11: Europe BCG Vaccine Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 12: Europe BCG Vaccine Market Revenue (USD Billion) Forecast, by Country, 2016-2027
Table 13: Latin America BCG Vaccine Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 14: Latin America BCG Vaccine Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 15: Latin America BCG Vaccine Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 16: Latin America BCG Vaccine Market Revenue (USD Billion) Forecast, by Country, 2016-2027
Table 17: Asia Pacific BCG Vaccine Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 18: Asia Pacific BCG Vaccine Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 19: Asia Pacific BCG Vaccine Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 20: Asia Pacific BCG Vaccine Market Revenue (USD Billion) Forecast, by Country, 2016-2027
Table 21: Middle East & Africa BCG Vaccine Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 22: Middle East & Africa BCG Vaccine Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 23: Middle East & Africa BCG Vaccine Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 24: Middle East & Africa BCG Vaccine Market Revenue (USD Billion) Forecast, by Country, 2016-2027
